3VM-12434-56368
2 vaccinations
7 coded responses
18 check-ins
7 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 920 / CA
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-28
Registered in v-safe
-
2021-03-28
Dose 1 — Pfizer-BioNTech
-
2021-03-28
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: Good · Fatigue or tirednessFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Survey response — days 1–6 daily, dose 1MedDRA: Pain — Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessFree text: Mild pain more annoying than troublesomeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 1MedDRA: Headache, Pain — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: All pain mild various areas and a slight headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness, Headache — Feeling: Fair · Headache, Fatigue or tirednessFree text: Dizzy yesterday and this morning, with headache.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Headache — Feeling: Good · Fatigue or tirednessFree text: Much better just the slightest headache.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: All good todayvvMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-04-11
-
2021-04-18
Dose 2 — Pfizer-BioNTech
-
2021-04-25
Survey response — day 7, dose 2MedDRA: Eye irritation, Fatigue, Headache, Injection site pain, Lacrimation increased, Ocular hyperaemia — Feeling: GoodFree text: Second day very fatigued injection site was more sore than the first but only lasted a day. Third day still fatigued and eye irritation very watery and red. Slight headache. No symptoms after that. Feel good now.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-02
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-05-31
- 2021-07-18
- 2021-10-19
- 2022-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-28 | Pfizer-BioNTech | |
| 2 | 2021-04-18 | Pfizer-BioNTech |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): None
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Mild pain more annoying than troublesome
Systemic reaction (other): All pain mild various areas and a slight headache
Systemic reaction (other): Dizzy yesterday and this morning, with headache.
Systemic reaction (other): Much better just the slightest headache.
Systemic reaction (other): All good todayvv
Release 7 — day 7, dose 2
Systemic reaction (other): Second day very fatigued injection site was more sore than the first but only lasted a day. Third day still fatigued and eye irritation very watery and red. Slight headache. No symptoms after that. Feel good now.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Eye irritation | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Lacrimation increased | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Ocular hyperaemia | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release